Plus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Plus Therapeutics using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-30 | $-0.04 | $-0.03 | -33.3 % |
| Q2 | 2025-08-14 | $-0.01 | $-0.11 | 90.9 % |
| Q1 | 2025-05-30 | $-1.19 | $-0.34 | -250.0 % |
| Q4 | 2025-03-27 | $-0.67 | $-0.50 | -34.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-30 | $1.40M | $1.78M | -21.7 % |
| Q2 | 2025-08-14 | $1.39M | $1.57M | -11.6 % |
| Q1 | 2025-05-30 | $1.06M | $1.11M | -4.59 % |
| Q4 | 2025-03-27 | $1.41M | $1.01M | 39.8 % |
Plus Therapeutics (PSTV) is scheduled to report earnings on March 26, 2026. The last reported earnings were for reported on October 30, 2025 for Q3.
The Actual EPS was $-0.04, which missed the estimate of $-0.03.
The Actual Revenue was $1.4M, which missed the estimate of $1.8M.
Browse earnings estimates, EPS, and revenue on all stocks.